MASON; Nicola

Patent Applications and Registrations

Patent applications and USPTO patent grants for MASON; Nicola.The latest application filed is for "treatment of a canine cd20 positive disease or condition using a canine cd20-specific chimeric antigen receptor".

Company Profile

1.6.9

MASON; Nicola - Philadelphia PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Treatment Of A Canine Cd20 Positive Disease Or Condition Using A Canine Cd20-specific Chimeric Antigen Receptor App 20220168351 - MASON; Nicola ; et al.	2022-06-02
Treatment of a canine CD20 positive disease or condition using a canine CD20-specific chimeric antigen receptor Grant 11,116,795 - Mason , et al. September 14, 2	2021-09-14
Treatment Of A Canine Cd20 Positive Disease Or Condition Using A Canine Cd20-specific Chimeric Antigen Receptor App 20190350972 - MASON; Nicola ; et al.	2019-11-21
Combination immuno therapy and radiotherapy for the treatment of Her-2-positive cancers Grant 10,016,617 - Mason , et al. July 10, 2	2018-07-10
Compositions And Methods For The Treatment Of Her2/neu Over-expressing Tumors App 20160361401 - Shahabi; Vafa ; et al.	2016-12-15
Compositions And Methods For Prevention Of Escape Mutation In The Treatment Of Her2/neu Over-expressing Tumors App 20150366955 - SHAHABI; VAFA ; et al.	2015-12-24
Compositions And Methods For Prevention Of Escape Mutation In The Treatment Of Her2/neu Over-expressing Tumors App 20150297702 - SHAHABI; VAFA ; et al.	2015-10-22
Compositions And Methods For Prevention Of Escape Mutation In The Treatment Of Her2/neu Over-expressing Tumors App 20150238584 - SHAHABI; VAFA ; et al.	2015-08-27
Combination Immuno Therapy And Radiotherapy For The Treatment Of Her-2-positive Cancers App 20150196628 - MASON; Nicola ; et al.	2015-07-16
Compositions and methods for prevention of escape mutation in the treatment of Her2/neu over-expressing tumors Grant 9,017,660 - Shahabi , et al. April 28, 2	2015-04-28
Single chain fragment variable antibody libraries and uses thereof Grant 8,722,587 - Mason May 13, 2	2014-05-13
Compositions And Methods For Treating An Activated B-cell Diffuse Large B-cell Lymphoma App 20130338080 - MASON; Nicola ; et al.	2013-12-19
Single Chain Fragment Variable Antibody Libraries And Uses Thereof App 20110158997 - Mason; Nicola	2011-06-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.